<DOC>
	<DOCNO>NCT00802659</DOCNO>
	<brief_summary>This study evaluate pain control quality life patient paraspinal metastasis , receive previous radiation therapy lesion , use single dose stereotactic radiotherapy .</brief_summary>
	<brief_title>A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery Control Pain</brief_title>
	<detailed_description>The goal study determine low dose radiation give effectively control tumor provide effective pain relief .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Age ≥ 18 Prior nonhematogenous , histologically proven malignancy ( specific exclusion multiple myeloma lymphoma ) Pain attributable one two radiographically apparent metastatic lesion ( ) amenable ESRT Have prior radiation area spine felt cause patient 's pain Zubrod performance status 03 Life expectancy ≥ 3 month Signed informed consent prior registration study Radiographic evidence stable disease outside spinal column least 6 week prior study entry , evaluate prestudy imaging . Women pregnant nursing Either 'no evidence active cancerous disease ' 'other site know disease locally control ' No radiographic evidence spinal instability ( e.g . spinal cord compression require immediate surgical intervention ) No initiation chemotherapy within 15 day trial entry . No plan concomitant antineoplastic therapy ( include standard fractionate RT , chemotherapy , biologic , vaccine therapy , surgery ) least 15 day follow stereotactic radiosurgery . No active systemic infection . No evidence myelopathy cauda equina syndrome clinical evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>